HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.

Abstract
ATP1A3, the gene encoding the α3-subunit of the Na(+) /K(+) -ATPase pump, has been involved in four clinical neurological entities: (1) alternating hemiplegia of childhood (AHC); (2) rapid-onset dystonia parkinsonism (RDP); (3) CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, sensorineural hearing loss) syndrome; and (4) early infantile epileptic encephalopathy. Here, we report on a 34-year-old female presenting with a new ATP1A3-related entity involving a relapsing encephalopathy characterized by recurrent episodes of cerebellar ataxia and altered consciousness during febrile illnesses. The term RECA is suggested - relapsing encephalopathy with cerebellar ataxia. The phenotype of this patient, resembling mitochondrial oxidative phosphorylation defects, emphasizes the possible role of brain energy deficiency in patients with ATP1A3 mutations. Rather than multiple overlapping syndromes, ATP1A3-related disorders might be seen as a phenotypic continuum.
AuthorsRodolphe Dard, Cyril Mignot, Alexandra Durr, Gaetan Lesca, Damien Sanlaville, Emmanuel Roze, Fanny Mochel
JournalDevelopmental medicine and child neurology (Dev Med Child Neurol) Vol. 57 Issue 12 Pg. 1183-6 (Dec 2015) ISSN: 1469-8749 [Electronic] England
PMID26400718 (Publication Type: Case Reports, Journal Article)
Copyright© 2015 Mac Keith Press.
Chemical References
  • ATP1A3 protein, human
  • Sodium-Potassium-Exchanging ATPase
Topics
  • Adult
  • Cerebellar Ataxia (etiology, genetics)
  • Consciousness Disorders (etiology, genetics)
  • Deglutition Disorders (etiology, genetics)
  • Female
  • Fever (complications)
  • Humans
  • Muscle Hypotonia (etiology, genetics)
  • Mutation
  • Phenotype
  • Recurrence
  • Sodium-Potassium-Exchanging ATPase (genetics)
  • Speech Disorders (etiology, genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: